April 2018 News & Views: AMCP Gathers Stakeholders to Develop Strategies on Sharing of HCEI AMCP Launches New Addiction Advisory Group to Address Opioid Crisis Not All Scientific Journals Are Created Equal: Beware Predatory Publishers
Leg-Reg Briefing April 2018: AMCP Annual Meeting Leg-Reg Sessions; Congress Sets Recess Schedule for Memorial Day; Action on Part D Biosimilars Costs in 2019
Press Release: AMCP Launches New Addiction Advisory Group (AAG) to Address Opioid Crisis Through Promotion of Best Practices, Innovative Care Models and Benefit Designs
The Academy of Managed Care Pharmacy (AMCP) writes to support and express concerns with specific provisions of Senate File 75. This legislation would regulate biological products and substitution of interchangeable biological products when dispensed by pharmacists.
The Academy of Managed Care Pharmacy (AMCP) strongly supports House Bill 1716. House Bill 1716 would allow carriers to request information for individual patient case reviews for determining medical necessity of a prescription, enhancing or coordinating patient care, or for assisting the treating provider’s clinical decision making, at the discretion of the Secretary of the Department of Health.